Skopos Labs, Inc. Haleon PLC Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Haleon PLC stock. As of the latest transaction made, Skopos Labs, Inc. holds 6,080 shares of HLN stock, worth $61,286. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,080
Previous 2,268
168.08%
Holding current value
$61,286
Previous $23,000
152.17%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding HLN
# of Institutions
659Shares Held
432MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.8 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$331 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$243 Million1.6% of portfolio
-
Wellington Management Group LLP Boston, MA15.3MShares$155 Million0.03% of portfolio
-
Morgan Stanley New York, NY9.89MShares$99.7 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $46.5B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...